Gilead Sciences (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD)


Share Price
$ 67.59
Change
1.22 (1.84 %)
Market Cap
$86,650.38 m
Proactive Investors - Run By Investors For Investors

Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.

EPIC: GILD
Market: NASDAQ:GILD
52-week High/Low: $82.71 / $60.32
Sector: Health Care, Equipment & Services
Market Cap: $86,650.40M
Website: www.gilead.com
col 3
col 4
col 5
col 6

Gilead Sciences Timeline

Market Reports Including GILD

VIEW ALL

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use